Physician profile
Brian Lee
NPI 1497088637
$18,133.59
in general payments reported to CMS, 2019-2025
13 companies · $2,931 in 2025
The $2,931 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $166 · 2021: $150 · 2022: $365 · 2023: $7,716 · 2024: $6,090 · 2025: $2,931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $2,893 · Food and Beverage: $1,969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,875.00 |
| Travel and Lodging | $2,892.72 |
| Food and Beverage | $1,969.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clearpoint Neuro, INC. | $9,265.46 | 2022-2025 | Clearpoint |
| Neuropace, INC. | $5,015.81 | 2022-2025 | |
| Abbott Laboratories | $2,040.15 | 2022-2025 | Infinity |
| Medtronic USA, INC. | $702.40 | 2019-2020 | |
| Boston Scientific Corporation | $546.85 | 2019-2025 | General - Dbs |
| Nuvasive, INC. | $161.17 | 2019 | |
| Mimedx Group, INC. | $133.92 | 2024 | |
| Histosonics, INC. | $115.93 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $57.07 | 2023-2024 | Jynarque |
| Ucb, INC. | $28.05 | 2025 | Rystiggo |
| Zimmer Biomet Holdings, INC. | $27.33 | 2023 | Stratum Foot Plating System |
| Medtronic, INC. | $25.21 | 2025 | Visualase |
| Livanova USA, INC. | $14.24 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.